Viewing Study NCT06482008


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-01-13 @ 3:01 PM
Study NCT ID: NCT06482008
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-01
First Post: 2024-06-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module